Skip to content
  • Home
  • IOncology
  • Infectious Desease Frontier
  • IHepatology
  • Hematology Frontier
  • Conference topics
  • Experts Interviews
  • Informations
  • Live Broadcasting
  • Logout
MediaMedic

Connecting Medical Expertise through Media

  • Home
  • IOncology
  • Infectious Disease Frontier
  • International Hepatology
  • Hematology Frontier
  • Conference topics
  • Experts’ Interviews
  • Informations
  • Home
  • IOncology
  • Infectious Disease Frontier
  • International Hepatology
  • Hematology Frontier
  • Conference topics
  • Experts’ Interviews
  • Informations

#CirrhosisManagement

Home » #CirrhosisManagement
Voice of China | Professor Jidong Jia and Professor Hong You’s Team: Carvedilol Combined with Antiviral Treatment Can Delay the Progression of Moderat

Voice of China | Professor Jidong Jia and Professor Hong You’s Team: Carvedilol Combined with Antiviral Treatment Can Delay the Progression of Moderat

Posted by By Mourabit Halima 2024.01.17
Editor's Note: Portal hypertension is the main pathophysiological cause of decompensation events in patients with cirrhosis and is a major driver of liver function deterioration. Non-selective β-blockers (NSBBs) are widely…
Read More
Recent Posts
  • AIDS 2026 | Interview with Dr. Claire Norcross: Analysis of HIV Drug Resistance Profiles and Implementation Strategies for Long-Acting Antiretroviral Regimens in African Populations
  • AIDS 2026 | Adriana Cervo: Focus on Long-Term Survival, Tumor Recurrence and Post-Transplant Metabolic Management Among HIV-Infected Liver Transplant Recipients
  • AIDS 2026 | Dr. Bascombe: Moving Beyond BMI to Address Occult Liver Injury in Lean HIV-Associated Fatty Liver Disease
  • AIDS 2026 | Dr. Alfredo Tagarro: Moving Beyond Transmission – In-Depth Exploration of Immune Profiles and Intervention Strategies in HIV-Exposed Infants and Young Children
  • 2026 Pujiang Urological Oncology Academic Conference丨Professor Dingwei Ye: Reshaping First-Line Treatment for Urothelial Carcinoma — Standardized Comprehensive Management to Maximize Long-Term Patient Benefit
Recent Comments
    Archives
    • September 2026
    • August 2026
    • July 2026
    • June 2026
    • May 2026
    • April 2026
    • March 2026
    • February 2026
    • January 2026
    • December 2025
    • November 2025
    • October 2025
    • September 2025
    • August 2025
    • July 2025
    • June 2025
    • May 2025
    • April 2025
    • March 2025
    • February 2025
    • January 2025
    • December 2024
    • November 2024
    • October 2024
    • September 2024
    • August 2024
    • July 2024
    • June 2024
    • May 2024
    • April 2024
    • March 2024
    • February 2024
    • January 2024
    • December 2023
    • November 2023
    • October 2023
    • August 2023
    Categories
    • Artificial intelligence
    • Hematology Frontier
    • Infectious Disease Frontier
    • International Hepatology
    • IOncology
    • Live broadcasting
    • Uncategorized
    • UroStream
    • LinkedIn
    • Twitter
    • Mail
    Related Media:
    Copyright 2026 — MediaMedic. All rights reserved. Blogun WordPress Theme
    Paris, France
    Scroll to Top